ARS Pharmaceuticals, Inc (SPRY) — Cash Flow Quality Index
ARS Pharmaceuticals, Inc (SPRY) has a Cash Flow Quality Index of 0.84x as of December 2024. Operating cash flow of $42.00 Million is below net income of $49.93 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore how large is ARS Pharmaceuticals, Inc's balance sheet for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ARS Pharmaceuticals, Inc Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for ARS Pharmaceuticals, Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check SPRY tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for ARS Pharmaceuticals, Inc (2024–2024)
Year-by-year earnings quality comparison for ARS Pharmaceuticals, Inc. For live market cap and the full company financial profile, see market value of ARS Pharmaceuticals, Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.69x | $13.55 Million | $8.00 Million | — |